| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |